| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |